Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific, Apogent Merger Gets FTC OK

NEW YORK, May 24 (GenomeWeb News) - Fisher Scientific and Apogent Technologies announced on Friday the expiration of the waiting period, required under US antitrust law, relating to their proposed $3.7 billion merger.

 

The companies said that the end of the waiting period indicates that the US Federal Trade Commission has completed its investigation into any potential antitrust violations associated with the deal and found that the companies meet all requirements.

 

The merger, first announced in March, is expected to close around July 1, said the companies.

 

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.